Literature DB >> 8751499

Hemodynamic alterations in bronchiectasis: a base for a new subclassification of the disease.

M Ashour1.   

Abstract

On the basis of the morphologic and hemodynamic features in 17 patients with bilateral bronchiectasis, a new subclassification is proposed. Accordingly, two types of bronchiectasis were recognized: perfused and nonperfused. Whereas perfused bronchiectasis has intact pulmonary artery flow and cylindrical bronchiectatic changes, the nonperfused type involves an absent pulmonary artery flow, retrograde filling of the pulmonary artery through the systemic circulation, and cystic bronchiectatic changes. A policy of unilateral resection of nonperfused bronchiectasis and preservation of the perfused type was adopted in 17 patients with bilateral bronchiectasis during an 8-year period. There were 9 women and 8 men with an average age of 28.6 +/- 7 years (range 18 to 48 years). Fifteen patients had mixed bronchiectasis (perfused type on one side and nonperfused on the other side) and two had localized bilateral nonperfused type. The average duration of follow-up was 38.3 +/- 24.9 months (range 13 to 111 months). In the 15 patients with mixed bronchiectasis, excellent (N = 8) or good (N = 7) results were achieved in all cases. On the other hand, the two patients with bilateral nonperfused bronchiectasis did not benefit from unilateral resection. This outcome implies that with perfused bronchiectasis the deranged function is likely to resolve with time. In the face of the general criticism of the traditional morphologic classification system, the proposed functional classification not only reflects the degree of severity of the disease process, but also predicts whether the involved lung will have a measure of respiratory function with regard to gas exchange. Thus the question of which side to resect and which to preserve is defined more precisely.

Entities:  

Mesh:

Year:  1996        PMID: 8751499     DOI: 10.1016/S0022-5223(96)70258-1

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Clinical characteristics of pulmonary hypertension in bronchiectasis.

Authors:  Lan Wang; Sen Jiang; Jingyun Shi; Sugang Gong; Qinhua Zhao; Rong Jiang; Ping Yuan; Bigyan Pudasaini; Jing He; Zhicheng Jing; Jinming Liu
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592

2.  HRCT score in bronchiectasis: correlation with pulmonary function tests and pulmonary artery pressure.

Authors:  Abdullaziz H Alzeer
Journal:  Ann Thorac Med       Date:  2008-07       Impact factor: 2.219

3.  Survival of bronchiectatic patients with respiratory failure in ICU.

Authors:  Abdulaziz H Alzeer; Mohammed Masood; Syed Jani Basha; Shaffi A Shaik
Journal:  BMC Pulm Med       Date:  2007-12-10       Impact factor: 3.317

4.  Pulmonary vascular pruning in smokers with bronchiectasis.

Authors:  Alejandro A Diaz; Diego J Maselli; Farbod Rahaghi; Carolyn E Come; Andrew Yen; Erick S Maclean; Yuka Okajima; Carlos H Martinez; Tsuneo Yamashiro; David A Lynch; Wei Wang; Gregory L Kinney; George R Washko; Raúl San José Estépar
Journal:  ERJ Open Res       Date:  2018-11-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.